Quarry LP Purchases 2,609 Shares of The Clorox Company (NYSE:CLX)

Quarry LP boosted its holdings in shares of The Clorox Company (NYSE:CLX) by 741.2% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 2,961 shares of the company’s stock after acquiring an additional 2,609 shares during the quarter. Quarry LP’s holdings in Clorox were worth $481,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in CLX. Vanguard Group Inc. raised its holdings in shares of Clorox by 0.8% during the 4th quarter. Vanguard Group Inc. now owns 15,507,152 shares of the company’s stock valued at $2,518,517,000 after purchasing an additional 124,428 shares in the last quarter. Geode Capital Management LLC raised its holdings in Clorox by 2.3% during the fourth quarter. Geode Capital Management LLC now owns 3,098,302 shares of the company’s stock valued at $501,925,000 after buying an additional 69,969 shares in the last quarter. Stifel Financial Corp lifted its position in shares of Clorox by 0.4% in the fourth quarter. Stifel Financial Corp now owns 2,344,408 shares of the company’s stock worth $380,761,000 after buying an additional 9,582 shares during the last quarter. Norges Bank bought a new stake in shares of Clorox during the 4th quarter worth about $259,041,000. Finally, FMR LLC increased its holdings in shares of Clorox by 75.4% during the 4th quarter. FMR LLC now owns 1,361,758 shares of the company’s stock valued at $221,163,000 after acquiring an additional 585,526 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Stock Performance

Shares of NYSE CLX opened at $138.28 on Monday. The firm has a market capitalization of $17.03 billion, a price-to-earnings ratio of 37.78, a PEG ratio of 2.62 and a beta of 0.61. The Clorox Company has a one year low of $127.60 and a one year high of $171.37. The business has a fifty day simple moving average of $145.61 and a 200 day simple moving average of $155.63. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the previous year, the business posted $2.16 earnings per share. Sell-side analysts expect that The Clorox Company will post 7.15 EPS for the current year.

Clorox Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be paid a $1.22 dividend. The ex-dividend date is Wednesday, April 23rd. This represents a $4.88 annualized dividend and a dividend yield of 3.53%. Clorox’s dividend payout ratio is currently 133.33%.

Analyst Ratings Changes

A number of brokerages have issued reports on CLX. Citigroup decreased their target price on Clorox from $165.00 to $150.00 and set a “neutral” rating for the company in a research report on Monday, April 14th. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $150.00 price objective on shares of Clorox in a report on Thursday, January 30th. Barclays dropped their target price on shares of Clorox from $139.00 to $134.00 and set an “underweight” rating on the stock in a report on Friday, April 11th. UBS Group decreased their price target on shares of Clorox from $176.00 to $154.00 and set a “neutral” rating for the company in a report on Thursday, April 17th. Finally, Wells Fargo & Company dropped their price objective on Clorox from $155.00 to $145.00 and set an “equal weight” rating on the stock in a research note on Wednesday, April 16th. Three equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has issued a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and an average price target of $153.83.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.